Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| ACER Options Chain |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on January 30, 2023, ACER opened at $2.45, traded as high as $2.45 and as low as $2.09, and closed at $2.27. Trading volume was a total of 257.60K shares. On January 31, 2023, ACER opened at $2.25, traded as high as $2.35 and as low as $2.25, and closed at $2.32. Trading volume was a total of 236.50K shares. On February 01, 2023, ACER opened at $2.33, traded as high as $2.36 and as low as $2.19, and closed at $2.28. Trading volume was a total of 499.10K shares. On February 02, 2023, ACER opened at $2.26, traded as high as $2.32 and as low as $2.13, and closed at $2.17. Trading volume was a total of 664.90K shares. On February 03, 2023, ACER opened at $2.22, traded as high as $2.27 and as low as $2.13, and closed at $2.22. Trading volume was a total of 206.10K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 02/06/2013 | |
| End date: | 02/03/2023 | |
| Start price/share: | $30.63 | |
| End price/share: | $2.22 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -92.75% | |
| Average Annual Total Return: | -23.09% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $724.67 | |
| Years: | 10.00 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 01/30/2023 | $2.45 | $2.45 | $2.09 | $2.27 | 257.60K |
| 01/31/2023 | $2.25 | $2.35 | $2.25 | $2.32 | 236.50K |
| 02/01/2023 | $2.33 | $2.36 | $2.19 | $2.28 | 499.10K |
| 02/02/2023 | $2.26 | $2.32 | $2.13 | $2.17 | 664.90K |
| 02/03/2023 | $2.22 | $2.27 | $2.13 | $2.22 | 206.10K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19. |
| ACER Historical Closing Prices | |
| Date | Close |
| 01/30/2023 | $2.27 |
| 01/31/2023 | $2.32 |
| 02/01/2023 | $2.28 |
| 02/02/2023 | $2.17 |
| 02/03/2023 | $2.22 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history
|
Free ACER Email Alerts:
